(CIDRAP News) – The World Health Organization (WHO) has called a Nov 11 "summit" meeting of health officials and vaccine companies to discuss how to confront what is seen as the growing risk that avian influenza will trigger a human flu pandemic.
(CIDRAP News) The revelation that samples of the influenza virus that caused the flu pandemic of 1957-58 were inadvertently sent to thousands of laboratories has raised fears of a new pandemic and triggered an urgent effort to destroy the samples.
(CIDRAP News) – US officials this week promoted international efforts to prepare for a potential influenza pandemic, announcing an international flu surveillance partnership and promising aid to Vietnam for avian and human flu surveillance.
(CIDRAP News) A new test developed by federal experts offers preliminary detection of H5 avian influenza in human patients in about 4 hours, compared with 2 to 3 days for other methods, government officials announced today.
(CIDRAP News) The company that markets oseltamivir (Tamiflu) in Japan has announced it will launch new studies to explore whether the antiviral drug contributes to adverse psychiatric and neurologic events in teenagers.
Editor's note: This is the last in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.
(CIDRAP News) European health officials today reported signs of an increasing rate of resistance to oseltamivir (Tamiflu) in Europe's predominant subtype of influenza virus, but they cautioned that the rate seen in isolates tested so far may not reflect the real situation.
(CIDRAP News) Two pharmaceutical companies that are developing a second-generation version of the inhaled antiviral drug zanamivir (Relenza) reported promising phase 2 results showing that one dose was as effective against influenza as a course of oseltamivir (Tamiflu).